Pediatric Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Pediatric Oncology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 68378
Special Issue Editors
Interests: pediatric cancers; neuroblastoma; cancer stem cells; metastasis; signaling pathways in cancer; immunotherapy; epigenetics; genetics; small molecule inhibitors; translational therapeutics; p53-myc interaction
Special Issues, Collections and Topics in MDPI journals
Interests: molecular mechanisms of cancer; differentiation; metastasis; neuroblastoma; target genes; therapeutic intervention; drug development
Special Issue Information
Dear Colleagues,
Childhood cancer or pediatric cancer is one of the leading causes of death among children. Treatment strategies for pediatric cancers include chemotherapy, surgery, radiation, and stem cell transplantation. These therapeutic regimens are well known to develop highly toxic and long-lasting side-effects including secondary cancers in the future lifespan of pediatric patients. Despite these intensive therapeutic regimens, cancer may still relapse as a refractory and metastatic cancer. Therefore, further understanding the causes of different pediatric cancers, mechanisms of drug-resistance, and causes of relapse and metastasis, are required for developing and advancing the less-toxic and more-effective therapeutic strategies for pediatric cancers. Recent advancements in immunotherapies and targeted therapeutic approaches using pharmacological inhibitors are one step in this direction. In this Special Issue of Cancers, we invite authors to contribute original research and review articles focusing on different aspects of pediatric cancer development, causes, maintenance, and therapeutic strategies. We will also consider articles on developmental targeted therapeutic approaches pertaining to any pediatric cancer. In this Special Issue, we will consider articles on different pediatric cancers including but not limited to, acute lymphoblastic leukemia, acute myeloid leukemia, astrocytoma, oligodendroglioma, ependymoma, choroid plexus carcinoma, oligoastrocytoma, glioblastoma, ganglioglioma, desmoplastic infantile ganglioglioma, anaplastic ganglioglioma, gangliocytoma, medulloblastoma, rhabdomyosarcoma, pineocytoma, osteosarcoma, Ewing sarcoma, neuroblastoma, Wilms tumors, retinoblastoma, non-Hodgkin lymphoma, Hodgkin lymphoma, pleuropulmonary blastoma, hepatoblastoma, and hepatocellular carcinoma. The collected articles in this Special Issue will further enhance our knowledge and understanding of pediatric cancers and drive the development of novel therapeutic strategies.
Dr. Saurabh Agarwal
Dr. Jianhua Yang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pediatric cancer
- Immunotherapy
- Tumorigenesis
- Metastasis
- Relapse
- Small molecule inhibitors
- Therapeutics
- Chemotherapy